Electrical Neuromodulation for Muscle Spasms

Not currently recruiting at 1 trial location
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Mississippi Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Muscle stiffness and muscle spasms are common after spinal cord injury. They can interfere with washing and dressing, moving between the bed and a wheelchair, walking, and sleep, and they can cause pain. Oral medications are the usual first-line treatment, but many people report limited benefit or side effects.

This study examines a non-surgical method called transcutaneous spinal stimulation. Surface electrodes are placed on the lower back and on the abdomen, and an electrical current is passed between them to activate nerve fibers entering the spinal cord.

Adults who have had a spinal cord injury and have muscle stiffness or spasms in the legs may participate. Each participant takes part in all parts of the study and serves as their own comparison. Participants attend four visits at one study site, about one week apart. The first visit is for consent and a clinical examination. At each of the next three visits, the participant receives one capsule containing tizanidine, baclofen, or an inactive substance (placebo), in an order assigned by chance. One hour later, the participant receives two 15-minute periods of spinal stimulation, one at 30 pulses per second and one at 75 pulses per second, also in an order assigned by chance. Neither the participant nor the person conducting the testing knows which capsule was taken.

Leg reflexes, muscle activity, and knee movement are measured before the capsule is taken, one hour after it is taken, during each period of stimulation, and after each period of stimulation. Clinical scales for stiffness and spasms are also scored. The study compares the two stimulation rates, compares stimulation with each medicine given alone, and examines whether adding stimulation to a medicine has a larger effect than stimulation alone.

Who Is on the Research Team?

MJ

Matthias J. Krenn, Ph.D.

Principal Investigator

University of Mississippi Medical Center

Are You a Good Fit for This Trial?

This trial is for adults with a spinal cord injury who have muscle stiffness or spasms in their legs. Participants must be able to attend four study visits and take part in all parts of the study.

Inclusion Criteria

History of spinal cord injury (ASIA Impairment Scale grades A-D)
Time since injury longer than six months
I am 18 years old or older.
See 2 more

Exclusion Criteria

I currently have an active infection.
Pregnancy
My spinal cord injury is below the T11 level.
See 10 more

What Are the Treatments Tested in This Trial?

Interventions

  • Baclofen
  • Tizanidine
  • Transcutaneous spinal stimulation at 30 Hz
  • Transcutaneous spinal stimulation at 75 Hz

Trial Overview

The study tests two types of non-surgical electrical stimulation (at 30 Hz and 75 Hz) applied to the lower back, as well as oral medications baclofen, tizanidine, and placebo. Each participant tries all treatments in different combinations.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Spinal stimulation with tizanidine, baclofen, or placeboExperimental Treatment5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Mississippi Medical Center

Lead Sponsor

Trials
185
Recruited
200,000+

Methodist Rehabilitation Center

Collaborator

Trials
7
Recruited
170+